Big Banks Boast High Profits While Junk Fees Continue to Cost Americans Billions
Report: Top 3 Chicken Producers Involved in DOJ Antitrust Lawsuit Racked Up Nearly $700M In Settlements For Price-and-Wage-Fixing
Gorsuch’s Billionaire Ties Threaten Supreme Court Integrity: In a Letter to Chief Justice Roberts, Advocacy and Watchdog Groups Demand Recusal in High-Stakes NEPA Case
Watchdog: In Defense of Scams, Big Auto Retailers Take FTC to Court in Industry-Friendly 5th Circuit
Supreme Court Green Lights Texas’ Near-Total Abortion Ban
Site Menu

Several Fifth Circuit judges have been found to hold significant financial interests in major pharmaceutical companies, raising serious concerns about conflicts of interest.

For example, Carter-appointed Judge Carolyn Dineen King owned up to $250,000 in AbbVie stock in 2022, while also serving on the boards of the Baylor College of Medicine and Menninger Clinic. Bush-appointed Judge Jacques L. Wiener, Jr. held shares in both AbbVie and Johnson & Johnson, and Clinton-appointed Judge James L. Dennis owned stock in Bristol Myers Squibb, Merck, and Amgen—companies represented on the influential Pharmaceutical Research and Manufacturers of America (PhRMA) board. These investments raise questions about the impartiality of judicial decisions that could impact the pharmaceutical industry, especially given AbbVie’s past membership in PhRMA.

Full Report
back to top